Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic combinations of orally administered irinotecan and a p-gp inhibitor for the treatment of cancer

Therapeutic combinations of orally administered irinotecan and a p-gp inhibitor for the treatment of cancer

US Patent 11752139 · Granted Sep 12, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Power generation and transfer using variable-pitch propeller2025
Durable antimicrobial treatment of textile for use in healthcare environment2025
Polymorphisms of HM30181 mesylate2025
Compositions and methods for broad-spectrum antiviral therapy2025
Automated disinfection device2025
Compositions and methods for enhancing immune response to vaccination and improv2024
Devices and methods for enhancing immunogenicity to intradermal vaccination2024
Oral taxane compositions and methods2024
Methods of preparing a pegylated human IL-11 composition2024
Compositions and methods for amino acid depletion therapy2024
Compositions and methods for treatment of enterovirus infection2023
Compositions and methods for treating hyperproliferative skin disorders2023